Pulmonx (LUNG) Competitors $1.61 -0.23 (-12.50%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.67 +0.06 (+3.66%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUNG vs. BFLY, DCTH, TMCI, SNWV, CATX, CLPT, OM, RXST, NPCE, and NNOXShould you be buying Pulmonx stock or one of its competitors? The main competitors of Pulmonx include Butterfly Network (BFLY), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Sanuwave Health (SNWV), Perspective Therapeutics (CATX), ClearPoint Neuro (CLPT), Outset Medical (OM), RxSight (RXST), NeuroPace (NPCE), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Pulmonx vs. Its Competitors Butterfly Network Delcath Systems Treace Medical Concepts Sanuwave Health Perspective Therapeutics ClearPoint Neuro Outset Medical RxSight NeuroPace Nano-X Imaging Butterfly Network (NYSE:BFLY) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk. Which has more volatility & risk, BFLY or LUNG? Butterfly Network has a beta of 2.45, meaning that its stock price is 145% more volatile than the S&P 500. Comparatively, Pulmonx has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Is BFLY or LUNG more profitable? Pulmonx has a net margin of -62.88% compared to Butterfly Network's net margin of -75.56%. Butterfly Network's return on equity of -29.97% beat Pulmonx's return on equity.Company Net Margins Return on Equity Return on Assets Butterfly Network-75.56% -29.97% -21.13% Pulmonx -62.88%-66.36%-35.51% Which has higher valuation & earnings, BFLY or LUNG? Pulmonx has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioButterfly Network$82.06M4.25-$72.49M-$0.29-4.86Pulmonx$83.79M0.77-$56.39M-$1.43-1.13 Do analysts prefer BFLY or LUNG? Butterfly Network currently has a consensus price target of $3.50, suggesting a potential upside of 148.23%. Pulmonx has a consensus price target of $7.66, suggesting a potential upside of 376.04%. Given Pulmonx's higher probable upside, analysts clearly believe Pulmonx is more favorable than Butterfly Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Butterfly Network 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Pulmonx 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56 Do insiders and institutionals hold more shares of BFLY or LUNG? 37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 25.2% of Butterfly Network shares are owned by company insiders. Comparatively, 6.8% of Pulmonx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media favor BFLY or LUNG? In the previous week, Pulmonx had 10 more articles in the media than Butterfly Network. MarketBeat recorded 20 mentions for Pulmonx and 10 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 0.82 beat Pulmonx's score of 0.01 indicating that Butterfly Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Pulmonx 2 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryButterfly Network and Pulmonx tied by winning 8 of the 16 factors compared between the two stocks. Get Pulmonx News Delivered to You Automatically Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUNG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUNG vs. The Competition Export to ExcelMetricPulmonxMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$74.07M$2.04B$5.48B$9.51BDividend YieldN/AN/A4.73%4.09%P/E Ratio-1.1333.7928.6723.80Price / Sales0.7728.84373.9066.58Price / CashN/A56.2135.4557.96Price / Book0.748.978.275.55Net Income-$56.39M-$62.31M$3.24B$259.03M7 Day Performance-51.80%-8.15%-3.69%-4.59%1 Month Performance-40.81%1.83%4.33%4.46%1 Year Performance-74.80%21.01%25.95%18.03% Pulmonx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUNGPulmonx3.855 of 5 stars$1.61-12.5%$7.66+376.0%-75.2%$74.07M$83.79M-1.13250Trending NewsEarnings ReportAnalyst ForecastHigh Trading VolumeBFLYButterfly Network2.6405 of 5 stars$1.89+0.8%$3.50+85.7%+36.9%$462.43M$82.06M-6.50460News CoverageAnalyst DowngradeGap DownDCTHDelcath Systems2.5218 of 5 stars$11.32+0.6%$24.00+112.0%+29.3%$391.80M$37.21M-22.6460Upcoming EarningsAnalyst UpgradeTMCITreace Medical Concepts2.4159 of 5 stars$5.72+1.2%$10.52+83.9%-19.0%$355.33M$209.36M0.00250News CoveragePositive NewsUpcoming EarningsSNWVSanuwave Health2.2594 of 5 stars$38.31-2.4%N/AN/A$336.26M$32.63M0.0040News CoverageAnalyst ForecastAnalyst RevisionCATXPerspective Therapeutics2.3837 of 5 stars$4.31+2.6%$12.56+191.3%-72.5%$319.92MN/A0.0070CLPTClearPoint Neuro2.73 of 5 stars$10.98-0.5%$25.00+127.7%+47.1%$308.72M$31.39M-14.45110Positive NewsAnalyst ForecastGap DownOMOutset Medical1.7102 of 5 stars$17.51+0.5%$29.50+68.5%-71.4%$308.72M$113.69M-0.60520Upcoming EarningsRXSTRxSight3.3717 of 5 stars$7.35flat$17.50+138.1%-82.4%$298.68M$139.93M0.00220Trending NewsUpcoming EarningsNPCENeuroPace3.264 of 5 stars$9.36+3.3%$17.00+81.6%+24.5%$297.15M$79.91M0.00170News CoverageNNOXNano-X Imaging2.213 of 5 stars$5.17+0.6%$9.50+83.8%-41.1%$296.98M$11.28M-5.74190News CoverageGap Down Related Companies and Tools Related Companies Butterfly Network Competitors Delcath Systems Competitors Treace Medical Concepts Competitors Sanuwave Health Competitors Perspective Therapeutics Competitors ClearPoint Neuro Competitors Outset Medical Competitors RxSight Competitors NeuroPace Competitors Nano-X Imaging Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUNG) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulmonx Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulmonx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.